Ono Pharmaceutical Reports Six-Month Operating Profit Growth
Group operating profit rose 11.2%; the company forecasts 2026/27 profit growth of 1.9%.
Related stories
Ind-Swift Laboratories Reports September-Quarter Consolidated Net Profit of 342.2 Million Rupees
L impact | EARNINGS | Oct 29, 2026, 09:31 AM UTC
Linde Reports Q3 Adjusted EPS of $4.59, Guides Q4 at $4.40–$4.50
Q3 adjusted EPS rose 9% year over year to $4.59 on sales of $9.40 billion, up 9%. Linde also guided full-year 2026 adjusted EPS to $17.82–$17.92.
M impact | EARNINGS | Oct 29, 2026, 09:30 AM UTC
BBVA Shares Fall 5.5% After Spain Earnings Miss Expectations
BBVA shares fell 5.5% in European morning trading after the bank reported weaker-than-expected third-quarter earnings in Spain.
M impact | EARNINGS | Oct 29, 2026, 09:30 AM UTC
Linde Reports Third-Quarter Adjusted EPS Up 9% Year Over Year
M impact | EARNINGS | Oct 29, 2026, 09:30 AM UTC
Linde Q3 Adjusted EPS Rises 9% to $4.59
M impact | EARNINGS | Oct 29, 2026, 09:29 AM UTC
Linde Sets 2026 Adjusted EPS Guidance at $17.82-$17.92
The company said the range represents 8% to 9% growth.
M impact | EARNINGS | Oct 29, 2026, 09:29 AM UTC